静脉氯胺酮与酮咯酸在胸部创伤患者中镇痛剂量的比较:一项随机双盲临床试验
这项三中心随机双盲临床试验将胸部创伤患者分为酮咯酸组(30 mg静脉注射,45例)和氯胺酮组(0.25 mg/kg静脉注射,45例),比较给药前及给药后30、60分钟的数字评分量表(NRS)疼痛评分,吗啡作为补救药物并记录不良事件。结果显示氯胺酮组在30分钟(中位NRS 3.0 vs 5.0,p=0.006)和60分钟(3.0 vs 5.6,p<0.001)的疼痛缓解均显著优于酮咯酸组;在留置胸腔引流管的患者中氯胺酮组疼痛控制也显著更好(p<0.001)。氯胺酮组需要更少的补救镇痛药物,但报告恶心更频繁。作者结论认为氯胺酮在急性情境下对伴或不伴肋骨骨折的胸部创伤患者是有效的镇痛药。
要点
- 胸部创伤患者静脉氯胺酮0.25 mg/kg在给药后30分钟NRS中位3.0(95%CI 2.8-3.5)优于酮咯酸30 mg静脉注射的5.0(95%CI 4.2-5.8),p=0.006。
- 给药后60分钟氯胺酮组NRS中位3.0(95%CI 2.7-3.7)仍优于酮咯酸组5.6(95%CI 4.7-6.4),p<0.001。
- 在留置胸腔引流管的患者中,氯胺酮组疼痛控制显著优于酮咯酸组(p<0.001)。
- 氯胺酮组需要更少的吗啡补救镇痛,但恶心报告更频繁。
- 作者认为氯胺酮可作为胸部创伤(伴或不伴肋骨骨折)急性期有效的镇痛选择。
适用人群与场景
- 胸部创伤患者,急性期,伴或不伴肋骨骨折,就诊于三所医院。
处置流程与药物剂量
- 氯胺酮组:氯胺酮0.25 mg/kg静脉注射,单次给药。
- 酮咯酸组:酮咯酸30 mg静脉注射,单次给药。
- 疼痛评估:给药前及给药后30、60分钟采用数字评分量表(NRS)评分。
- 补救镇痛:使用吗啡。
研究设计与关键结果
- 研究设计:随机双盲临床试验,在三所医院开展,共90例胸部创伤患者,氯胺酮组45例、酮咯酸组45例。
- 主要终点:给药后30分钟NRS中位(IQR)95%CI,氯胺酮组3.0(1.0)2.8-3.5 vs 酮咯酸组5.0(4.5)4.2-5.8,p=0.006。
- 给药后60分钟NRS中位(IQR)95%CI,氯胺酮组3.0(2.0)2.7-3.7 vs 酮咯酸组5.6(1.7)4.7-6.4,p<0.001。
- 留置胸腔引流管的患者中,氯胺酮组疼痛控制显著优于酮咯酸组(p<0.001)。
- 氯胺酮组需要更少的补救镇痛药物,但报告恶心更频繁。
证据类型、等级与局限
- 证据类型:随机双盲临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于胸部创伤急性期患者(伴或不伴肋骨骨折),静脉氯胺酮0.25 mg/kg可提供优于酮咯酸30 mg静脉注射的镇痛效果,且减少补救镇痛需求,但需注意恶心。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pain management is a critical part of treatment in patients with chest trauma. Opioids and nonsteroidal anti-inflammatory drugs have been the most commonly used medications. However, their side effects have drawn attention to other medications. In this study, we aimed to assess the effect of the analgesic dose of ketamine in patients with chest trauma in comparison to ketorolac.
METHODS: A randomized, double-blind clinical trial was conducted in three hospitals. Patients were randomly allocated into two groups: 45 in the ketorolac group (30 mg intravenous [IV] and 45 in the ketamine group [0.25 mg/kg IV]). Pain was rated via numeric rating scale (NRS) before and 30 and 60 min after the drug injection. Morphine was used as the rescue medication. Furthermore, the adverse events of the two study regimens were rated.
RESULTS: Pain was more significantly relieved in the ketamine group, 30 and 60 min after drug administration, compared to ketorolac (median [IQR] 95% CI 30-min NRS 3.0 [1.0] 2.8-3.5 vs. 5.0 [4.5] 4.2-5.8, p = 0.006; and 60-min NRS 3.0 [2.0] 2.7-3.7 vs. 5.6 [1.7] 4.7-6.4, p < 0.001), respectively. Among patients with a chest tube, pain was more significantly controlled in the ketamine group (p < 0.001). Also, patients in the ketamine group needed less rescue pain medications compared to the ketorolac group although they reported more frequent nausea.
CONCLUSION: Ketamine can be an effective analgesic in patients with chest trauma in acute settings with or without rib fracture.
参考来源
- Mahmoodabadi HZ, Javadein ZS, Moosaie F, et al. Comparison of the analgesic dose of intravenous ketamine versus ketorolac in patients with chest trauma: A randomized double-blind clinical trial. Acad Emerg Med. 2024. PMID: 39737775. doi:10.1111/acem.15050
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。